Skip to content

Ketamine for PTSD: all studies

Page 4 of 13: studies 31 to 40 of 130, newest first. Back to the ketamine for PTSD overview

Research

Esketamine attenuates post-traumatic stress disorder via suppressing neuroinflammation and abnormal myelination.

Neurochemistry International November 19, 2025 Zhaoliang Gu, Ruixue Song, Guoqiang Liu et al. 3 citations

Post-traumatic stress disorder (PTSD) is a chronic psychological disorder that is induced by traumatic events. The pathophysiological mechanism of PTSD involves complex neurobiological processes. However, the underlying mechanism is not clear, leading to lack of effective therapeutic interventions. Mice were exposed to the electric foot shocks using the contextual fear memory paradigm. A...

DOI: 10.1016/j.neuint.2025.106089 (opens in new tab) Full text (opens in new tab) Fear memory Myelination Neuroinflammation Esketamine For PTSD +1

Ketamine Assisted EMDR Therapy™ for PTSD: investigating the synergistic effects of pharmacotherapy and psychotherapy

European Journal of Psychotraumatology November 4, 2025 Michele Topel, Donald S. Ciccone 2 citations

Background: Posttraumatic stress disorder (PTSD) is associated with maladaptive memory reconsolidation and overgeneralized fear responses. EMDR therapy promotes trauma reprocessing by activating the brain's intrinsic memory reconsolidation mechanism, facilitating memory updating, and abandoning outdated emotional schemas. Ketamine may also facilitate adaptive updating of traumatic memory due to...

DOI: 10.1080/20008066.2025.2572861 (opens in new tab) Ketamine Memory consolidation Clinical psychology Psychotherapist +6

Epigenetic aging and DNA methylation biomarker changes following ketamine treatment in patients with MDD and PTSD: a pilot study.

Translational Psychiatry October 31, 2025 Kristin L Dawson, Athena May Jean M. Carangan, Jessica Klunder et al. 2 citations

Major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are debilitating psychiatric conditions associated with poor health outcomes similarly observed in non-pathological aging. Ketamine is a dissociative anesthetic and NMDA receptor antagonist with demonstrated rapid reduction in symptoms associated with Treatment Resistant Depression (TRD) and PTSD. Ketamine's effects on...

Ketamine for treatment-resistant post-traumatic stress disorder: double-blind active-controlled randomised crossover study

BJPsych Open October 1, 2025 Ben Beaglehole, Paul Glue, Shona Neehoff et al. 5 citations

We provide preliminary support for the efficacy and tolerability of i.m. ketamine in a community sample of individuals with PTSD. Further work is required to establish the optimal dosing regimen and longer-term role of ketamine in treatment of PTSD, but our findings are encouraging given the well-known of treatments in this area.

Time‐Dependent Therapeutic Effect of S ‐Ketamine on PTSD Mediated by VTA‐OFC Dopaminergic Neurocircuit

Advanced Science September 25, 2025 Ye Wang, Lei Liu, Jinghao Wang et al. 2 citations

Current pharmacotherapies for post-traumatic stress disorder (PTSD) are limited by delayed onset and side effects. Despite ketamine exhibiting rapid relief of the core symptoms of PTSD, its clinical efficacy varies considerably depending on the timing of drug delivery. However, the underlying mechanism remains unclear. In this study, the therapeutic effects of early (day 1) and late (day 7)...

DOI: 10.1002/advs.202500805 (opens in new tab) Mechanism biology Therapeutic effect Therapeutic approach Drug +4

Self-Reported Improvements in Comorbid Post-Traumatic Stress Disorder Symptoms, Depression, Anxiety, and Sleep Among Real-World Patients Receiving Medical Ketamine: Exploring the Role of Adjunct Therapies.

European Journal of Trauma & Dissociation September 1, 2025 Shahar Almog, Albert Garcia‐romeu, Kathryn Walker et al. 1 citation

Post-traumatic stress disorder (PTSD) presents severe symptomology and often co-occurs with depression, warranting novel treatment approaches to address both conditions simultaneously. Ketamine has emerged as a rapid antidepressant and potential treatment for PTSD, with some real-world evidence for effectiveness regardless of comorbidities. The purpose of this secondary analysis was to explore...

A retrospective analysis of ketamine intravenous therapy for post-traumatic stress disorder in real-world care settings.

Psychiatry Research August 20, 2025 L. Mcinnes, Robert M. Berman, Matthew J Worley et al.

OBJECTIVE The study evaluated the effectiveness of Ketamine Intravenous Therapy (KIT) in reducing post-traumatic stress disorder (PTSD) and depression symptoms, using electronic health record data from outpatient psychiatric patients with PTSD. METHOD We analyzed data from 8,136 patients diagnosed with PTSD, 87 % (N = 7,070) of whom also had comorbid depression. Symptom severity was measured...

Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review.

Cureus August 1, 2025 Brett Hughes, Soz Mirza, Manasi Ponamala et al.

The stresses of the Coronavirus Disease of 2019 (COVID-19) pandemic highlighted the burden of psychiatric disorders within the pediatric population, revealing a pre-existing need for rapid-onset therapies that have since driven efforts to expand effective therapeutic interventions. In this narrative review, we utilized the Preferred Reporting Items for Systematic reviews and Meta-Analysis...

An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions.

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 25, 2025 Kiana Askariyan, Mohammad Taghi Joghataei, Samaneh Dehghan et al. 9 citations

The resurgence of psychedelic-assisted psychotherapy marks a pivotal evolution in mental health treatment, challenging traditional paradigms by integrating compounds such as psilocybin, LSD, MDMA, and ketamine into clinical practice. Historically marginalized due to regulatory and societal concerns, these agents are now gaining recognition for their unique neurobiological mechanisms and...

Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample.

Journal of Affective Disorders July 15, 2025 Tyler M Moore, Kathryn Walker, Emma Tung et al. 8 citations

Depression and PTSD are prevalent psychiatric conditions that often co-occur and significantly impact quality of life. Ketamine has emerged as a promising rapid-acting treatment for both conditions, while traditional treatments like psychotherapy typically require weeks to show effects. This study investigated whether combining ketamine with psychotherapy produces greater symptom improvement...

DOI: 10.1016/j.jad.2025.04.041 (opens in new tab) Full text (opens in new tab) Post-traumatic stress Psychotherapy Mental health Depression therapy +3